Advances Non Opioid Analgesia Pioneering Pain Management

!{.series-logo}

!

Advances in Non-Opioid Analgesia: Pioneering Pain Management for Laboratory Animals 🐾💊
=======

Created on 2025-01-08 22:52

Published on 2025-01-09 12:00

————————————————————————

Advances in Non-Opioid Analgesia in Laboratory Animal Science

In recent years, the field of laboratory animal science has seen
significant advancements in the development of non-opioid analgesics for
pain management. These developments are crucial for improving animal
welfare and ensuring the reliability of experimental data. Traditional
pain management in laboratory animals has heavily relied on opioids,
which, while effective, come with a host of side effects and potential
for abuse. The shift towards non-opioid options is a promising step
forward.

Recent Developments in Non-Opioid Analgesics

One of the most exciting areas of research is the development of
non-opioid analgesic peptides. These peptides target various ion
channels and receptors involved in pain pathways, such as Ca2+, Na+, and
K+ voltage-gated ion channels, as well as transient receptor potential
channels (TRP) and non-opioid G-protein coupled receptors (GPCRs) (De
Vega et al., 2018). This approach not only provides effective pain
relief but also minimizes the side effects associated with traditional
opioids.

Moreover, there has been an increase in the use of non-steroidal
anti-inflammatory drugs (NSAIDs) and local anesthetics in laboratory
settings. A systematic review comparing studies from 2009 and 2019 found
that the use of these non-opioid analgesics in craniotomy procedures for
mice and rats has increased, although the overall reporting of
multimodal analgesic treatments remains low (King et al., 2023). This
highlights the ongoing need for improved training and awareness in the
use of non-opioid analgesics.

Challenges and Opportunities

Despite these advancements, challenges remain in the consistent
application and reporting of non-opioid analgesia in laboratory
settings. A review of pain management practices in pigs undergoing
experimental surgery revealed that while many studies use drugs with
analgesic properties, the reporting of postoperative analgesia is often
inadequate (Bradbury et al., 2016). This under-reporting can lead to
inconsistencies in data and animal welfare concerns.

Furthermore, the development of new pain assessment methods, such as
functional MRI and gait analysis, offers promising tools for evaluating
the efficacy of non-opioid analgesics in preclinical settings (Cortright
et al., 2008). These methods could enhance the predictive utility of
pain relievers and improve the translation of analgesic compounds from
animal models to human therapeutics.

Share Your Experience

Have you tried non-opioid options in pain management for laboratory
animals? Your experiences and insights could be invaluable in advancing
this field. Share your thoughts and contribute to the ongoing
conversation about improving animal welfare and research outcomes
through innovative pain management strategies.

In summary, the shift towards non-opioid analgesics in laboratory animal
science represents a significant advancement in both animal welfare and
research integrity. Continued research and improved reporting practices
are essential to fully realize the potential of these new analgesic
options.

————————————————————————

References

Bradbury, A., Michael Eddleston, e R. Clutton. “Pain management in pigs
undergoing experimental surgery; a literature review (2012-4).” *British
journal of anaesthesia* 116 1 (2016): 37–45.
.

Carbone, L., e Jamie Austin. “Pain and Laboratory Animals: Publication
Practices for Better Data Reproducibility and Better Animal Welfare”.
PLoS ONE 11 (12 de maio de 2016).
.

Cortright, D., D. Matson, e D. Broom. “New frontiers in assessing pain
and analgesia in laboratory animals”. Expert Opinion on Drug Discovery
3 (21 de agosto de 2008): 1099–1108.
.

De Vega, M. Pérez, A. Ferrer-Montiel, e R. González-Muñiz. “Recent
progress in non-opioid analgesic peptides.” *Archives of biochemistry
and biophysics* 660 (1o de dezembro de 2018): 36–52.
.

Flecknell, P. “The relief of pain in laboratory animals”. *Laboratory
Animals* 18 (1o de abril de 1984): 147–60.
.

Jirkof, P. “Side effects of pain and analgesia in animal
experimentation”. Lab Animal 46 (22 de março de 2017): 123–28.
.

King, Hannah, Maria Reiber, Vanessa Philippi, Helen Stirling, Katharina
Aulehner, M. Bankstahl, A. Bleich, et al. “Anesthesia and analgesia for
experimental craniotomy in mice and rats: a systematic scoping review
comparing the years 2009 and 2019″. Frontiers in Neuroscience 17 (3 de
maio de 2023). .

Pinheiro, Ana Vidal, G. Petrucci, Amândio Dourado, Filipe Silva, e
Isabel Pires. “Pain Management in Animals with Oncological Disease:
Opioids as Influencers of Immune and Tumor Cellular Balance”. Cancers
16 (29 de agosto de 2024). .

Richardson, C., e P. Flecknell. “Anaesthesia and Post-operative
Analgesia following Experimental Surgery in Laboratory Rodents: Are we
Making Progress?” Alternatives to Laboratory Animals 33 (1o de abril
de 2005): 119–27. .

Slingsby, L. “Considerations for prospective studies in animal
analgesia.” Veterinary surgery : VS 39 5 (3 de março de 2010):
532–34. .

Ver original no LinkedIn

Deixe um comentário

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *